Covishield shows better antibody response than Covaxin, says study
By Administrator_India Capital Sands Indian health care workers who were administered Covishield have shown better
Coronavirus
Bharat Biotech reduces price of Covaxin for states to Rs 400 per dose
By Administrator_India Capital Sands Taking cue from Serum Insistute of India, Hyderbad-based Bharat Biotech on
Holi celebrations banned in Mumbai amid spike in COVID-19 cases
By Administrator_India Capital Sands Amid an alarming surge in COVID-19 cases in Mumbai, the Brihanmumbai
Serum, Bharat Biotech vaccines get restricted use approval from DCGI
By Administrator_India Capital Sands India’s drug regulator on Sunday gave its final approval to the
Delhi raises fines for not wearing masks to Rs 2,000 as Covid cases rise
By Administrator_India Capital Sands Delhi Chief Minister Arvind Kejriwal on Thursday announced hiking fines for not using
Coronavirus update: As Delhi wrestles third wave, survey finds 74% residents favour shutting down markets, shops
By Administrator_India Capital sands Over 74 percent of people in Delhi, which has seen a
India reports spike of 50,209 new coronavirus cases in last 24 hours, tally at 83.64 lakh
By Administrator_ India Capital Sands With a jump of 50,209 new Covid-19 cases in the last 24
Johnson & Johnson to test single-shot coronavirus vaccine on 60,000 people in phase-3 trials
By Administrator_ India Capital Sands Pharmaceutical giant Johnson & Johnson (J&J) has begun the phase-three trials
Serum Institute says claims surrounding COVISHIELD’s availability in 73 days are false
By Administrator_India Capital Sands Serum Institue of India issued a statement on August 23, clarifying
More businesses in India re-open even as COVID-19 cases surge
By Administrator_India Capital Sands India reported on Wednesday 52,509 new cases over the novel coronavirus,